Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (160) Amyotrophic Lateral Sclerosis (ALS)
...CenterWatch: Clinical Trials in Category (160) Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) State • Massachusetts • New York Massachusetts Boston : Massachusetts General Hospital New! A Multicenter Study for the ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (160), Amyotrophic Lateral Sclerosis (ALS)
...CenterWatch: New Medical Therapies in Disease Category (160), Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) Patient Medical Areas • Neurology December 10, 2007 Avicena released positive results from a phase II ...
View Page

3.  Study Posting (180) Trial #90595, Amyotrophic Lateral Sclerosis (ALS), New York, NY
...Study Posting (180) Trial #90595, Amyotrophic Lateral Sclerosis (ALS), New York, NY Trial Information Multi-center Phase II Combination Therapy Selection Trials in ALS The Investigator-initiated trial is set to begin in Spring 2006 and will be conducted ...
View Page

4.  Study Posting (180) Trial #90310, Amyotrophic Lateral Sclerosis (ALS), New York, NY
...Study Posting (180) Trial #90310, Amyotrophic Lateral Sclerosis (ALS), New York, NY Trial Information Multi-center Phase II Combination Therapy Selection Trial In ALS The Investigator-initiated trial is set to begin in Spring 2006 and will be conducted ...
View Page

5.  Study Posting (799) Trial #157473, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #157473, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Electrical Impedance Myography as an Outcome Measure in ALS Clinical Trials Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clincal Trials ...
View Page

6.  Study Posting (799) Trial #157469, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #157469, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Electrical Impedance Myography as an Outcome Measure in ALS Clinical Trials Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clincal Trials ...
View Page

7.  Study Posting (799) Trial #163139, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #163139, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Clinical Trial of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics ...
View Page

8.  Study Posting (799) Trial #163131, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #163131, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Clinical Trial of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics ...
View Page

9.  Study Posting (799) Trial #156966, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #156966, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Clinical Trial of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics ...
View Page

10.  Study Posting (799) Trial #156977, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #156977, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information A Multicenter Study for the Validation of ALS Biomarkers Newsletter/Web Posting Massachusetts General Hospital is seeking individuals to participate in a specimen ...
View Page

11.  Study Posting (180) Trial #81052, Amyotrophic Lateral Sclerosis (ALS), New York, NY
...Study Posting (180) Trial #81052, Amyotrophic Lateral Sclerosis (ALS), New York, NY Trial Information Clinical Trial of High Dose CoQ10 in ALS Background information: Research implicates that mitochondria, the powerhouses of the cell, are affected in Lou ...
View Page

12.  Study Posting (2348) Trial #94801, Amyotrophic Lateral Sclerosis (ALS), New York, NY
...Study Posting (2348) Trial #94801, Amyotrophic Lateral Sclerosis (ALS), New York, NY Trial Information Investigative Studies on the Effect of Lowering SOD1 Levels in ...
...Sclerosis (FALS) What is the purpose of this research study? The familial (inherited) form of ALS may be caused by a mistake (mutation) in the gene that contains instructions for making ...
View Page

13.  Study Posting (799) Trial #156979, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #156979, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Phase II/III, Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis Announcement Research participants with Familial Amyotrophic Lateral Sclerosis (ALS) are currently being recruited in the United States for a two-center ‘Phase II/III ...
View Page

14.  Study Posting (799) Trial #159984, Amyotrophic Lateral Sclerosis (ALS), Boston, MA
...Study Posting (799) Trial #159984, Amyotrophic Lateral Sclerosis (ALS), Boston, MA Trial Information Feasibility of the BrainGate2 Neural Interface System in Persons with Tetraplegia ...
...cord injury, brainstem stroke, muscular dystrophy, or motor neuron disease such as amyotrophic lateral sclerosis (ALS) and have no or limited use of their hands are needed for an FDA regulated ...
View Page

15.  Study Posting (799) Trial #156976, *Healthy Patient Studies, Boston, MA
...156976, *Healthy Patient Studies, Boston, MA Trial Information Clinical Trial of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics ...
...in brain and has antioxidant properties. Ceftriaxone prolongs survival of a transgenic mouse model of ALS [1]. Preclinical evidence suggests that the extracellular accumulation of excitatory amino acids (EAAs) such as ...
View Page

16.  CenterWatch: New Medical Therapies in Disease Category (103), Musculoskeletal Diseases
...from a phase II trial of AL-08 for the treatment of Amyotrophic Lateral Sclerosis (ALS). This randomized, double-blind, selection trial enrolled one hundred and twenty subjects who received AL ...
...to determine treatment selection based on which drug combination appeared to slow deterioration in the ALS-Functional Score. Results showed subjects treated with AL-08/celcoxib showed a smaller mean functional ...
View Page

17.  Study Posting (2348) Trial #94803, Neuropathy, New York, NY
...Unique abnormalities have been identified in the spinal fluid and blood of some patients with ALS and motor neuropathy that may be specific for the illness. The concentration of these molecules ...
...the illness and identify more effective treatments. This study does not offer any treatment for ALS or other neurological diseases. It may help us to better understand neurological diseases and to ...
View Page

18.  CenterWatch New Medical Therapies™ in Neurology
...in Neurology Neurology Acute Pain Adverse Effects, Drugs Aging Alzheimer's Disease Amyotrophic Lateral Sclerosis (ALS) Anesthesia Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Autism Brain ...
View Page

19.  CenterWatch: Clincial Trial Listings in Neurology
...in Neurology Aging   (9, 7 New! ) Alzheimer's Disease   (230, 34 New! ) Amyotrophic Lateral Sclerosis (ALS)   (5, 4 New! ) Aneurysm   (7, 5 New! ) Attention Deficit/Hyperactivity Disorder (ADHD - Adults)   (24, 9 ...
View Page

20.  Study Posting (799) Trial #156968, *Healthy Patient Studies, Boston, MA
...in SOD1 Positive Familial Amyotrophic Lateral Sclerosis Announcement Research participants with Familial Amyotrophic Lateral Sclerosis (ALS) are currently being recruited in the United States for a two-center ‘Phase II/III ...
View Page